首页> 外文OA文献 >Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled non-inferiority trial

【2h】

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled non-inferiority trial

机译：达格列净与格列吡嗪作为二甲双胍血糖控制不足的2型糖尿病患者的附加治疗：一项随机，为期52周，双盲，主动控制的非劣效性试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
NAUCK MA; DEL PRATO S; MEIER JJ; DURAN-GARCIA S; ROHWEDDER K; ELZE M; PARIKH SJ;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial [Vergleich von Dapagliflozin und Glipizid als Add-on-Therapie bei Typ-2-Diabetikern mit unzureichender Blutzuckerkontrolle unter Metformin: Eine randomisierte, doppelblinde, verumkontrollierte Nichtunterlegenheitsstudie über 52 Wochen] [J] . NauckM., DelPratoS., MeierJ.J., DMW: Deutsche Medizinische Wochenschrift . 2013,第S1期

机译：Dapagliflozin与glipizide联合治疗对二甲双胍血糖控制不足的2型糖尿病患者：一项随机，为期52周，双盲，主动控制的非劣效性试验[dapagliflozin和glipizide作为附加治疗的比较血糖控制不佳的二型糖尿病患者服用二甲双胍：一项52周的随机，双盲，经血清控制的非劣效性研究]
2. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial. [J] . Nauck MA, Del Prato S, Meier JJ, Diabetes care . 2011,第9期

机译：达格列净与格列吡嗪作为二甲双胍血糖控制不足的2型糖尿病患者的附加治疗：一项随机，为期52周，双盲，主动控制的非劣效性试验。
3. Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: Long-term (52-week) extension of a 52-week randomised controlled trial [J] . International journal of clinical practice . 2013,第4期

机译：Saxagliptin与粘嘧啶作为2型糖尿病患者的附加疗法单独对二甲双胍的不充分控制：长期（52周）延长52周随机对照试验
4. EFFECT OF TARGETED PULSED ELECTROMAGNETIC FIELD THERAPY ON CANINE POST-OPERATIVE HEMILAMINECTOMY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL [C] . ACVS Veterinary Symposium . 2018

机译：靶向脉冲电磁场治疗对犬术后血栓切除术的影响：双盲，随机，安慰剂对照临床试验
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin [O] . Michael A. Nauck, Stefano Del Prato, Juris J. Meier, 2011

机译：达格列净与格列吡嗪相比二甲双胍的血糖控制不足的2型糖尿病患者可作为附加疗法
7. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin : a randomized, 52-week, double-blind, active-controlled noninferiority trial [O] . Nauck, Michael, Del Prato, Stefano, Meier, Juris, 2011

机译：达格列净与格列吡嗪作为二甲双胍血糖控制不足的2型糖尿病患者的附加疗法：一项随机，为期52周，双盲，主动控制的非劣效性试验

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled non-inferiority trial

著录项

相似文献

相关主题

期刊订阅